Loading…
Identifying putative cerebrospinal fluid biomarkers of amyotrophic lateral sclerosis in a north Indian population
Introduction Evidence‐based information about cerebrospinal fluid (CSF) levels of biomarkers in patients with amyotrophic lateral sclerosis (ALS) is limited. Methods Vascular endothelial growth factor (VEGF) and its receptor vascular endothelial growth factor receptor 2 (VEGFR2), optineurin (OPTN),...
Saved in:
Published in: | Muscle & nerve 2020-10, Vol.62 (4), p.528-533 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Introduction
Evidence‐based information about cerebrospinal fluid (CSF) levels of biomarkers in patients with amyotrophic lateral sclerosis (ALS) is limited.
Methods
Vascular endothelial growth factor (VEGF) and its receptor vascular endothelial growth factor receptor 2 (VEGFR2), optineurin (OPTN), monocyte chemoattractant protein‐1 (MCP‐1), angiogenin (ANG), and TAR DNA‐binding protein (TDP‐43) were quantified by enzyme‐linked immunoassay in the CSF of 54 patients with sporadic ALS and 32 controls in a case‐control study design.
Results
CSF levels of VEGF (P = .014) and ANG (P = .009) were decreased, whereas VEGFR2 was higher (P = .002) in patients with ALS than in controls. TDP‐43 positively correlated with MCP‐1 (P = .003), VEGF (P |
---|---|
ISSN: | 0148-639X 1097-4598 |
DOI: | 10.1002/mus.27026 |